24 March 2017

ParkinsonNet has receives a Parel award by The Economic Board. ParkinsonNet aims to improve the lives of people affected by Parkinson. The Parel award goes to companies and organizations that distinguish themselves through innovation, and aims to raise awareness for them.

Together with 3000 health care professionals, ParkinsonNet aims to improves life for people affected by Parkinson. "Through innovative technology en specialized treatment, we can educate patients", says Bas Bloem, professor of neurological movement disorders at Radboudumc, researcher at the Donders Institute, and co-founder of ParkinsonNet.

The results achieved by ParkinsonNet did not go unnoticed outside of the Netherlands: several networks have come into existence around the organization. Moreover, it has begun to cooperate with the life science company Verily.

"We are very happy with the Parel award, as it reflects recognition for the economical value of ParkinsonNet by a third, unrelated party. That is not our goal, but it furthers our ambition to help people across the globe and to foster collaboration with private parties."

The Parel award and The Economic Board
Started in 2016, this has been the second time that the Parel awards were awarded by The Economic Board. This year it was also awarded to Kraft Heinz and Allego. The Parel award distinguishes companies and organizations that, in the view of The Economic Board, excel through innovation.

The Economic Board is a Triple Helix collaboration between the state, research institutes, and private companies in the region Arnhem - Nijmegen and the city of Wageningen. This part of the Netherlands is considered a bulwark for food, health care, energy, and the corresponding state-of-the-art research. It is the intent of The Economic Board to communicate the potential of this region and to bring together entrepeneurs, investors, education, research, and the state.

Related news items


Social media posts on medication use during pregnancy often incorrect

23 August 2019

Dutch social media regularly post about the safety of medicines for pregnant women. Many pregnant women use these posts as a source of information. A new analysis shows, however, that information found on social media about the risk of medication use often does not correspond with guidelines.

read more

Hans van Bokhoven newly elected in Academia Europaea

22 August 2019

The Academia Europaea is a functioning European Academy of Humanities, Letters and Sciences, composed of individual members.

read more

Drug-induced interstitial lung disease in advanced breast cancer patients receiving everolimus

22 August 2019

In Targeted Oncology, Annelieke Willemsen, Carla van Herpen and colleagues, showed that pulmonary function test with diffusion capacity of the lungs for carbon monoxide and serum biomarkers can be of aid to differentiate everolimus-related interstitial lung disease from other respiratory problems.

read more

Publication in PNAS on dissecting EEC syndrome using single-cell RNA-seq

22 August 2019

PhD candidates Eduardo Soares and Quan Xu in Jo Huiqing Zhou’s group in Molecular Developmental Biology, theme Reconstruction and regenerative medicine, have published a paper in PNAS on the disease mechanism of EEC syndrome using single-cell RNA-seq technology and patient-derived iPSCs.

read more

Patient trust and participation in cell biological research

21 August 2019

Alessandra Cambi and Gert Olthuis, discuss key ethical issues inherent in the development and the value of building trust and trustworthiness.

read more

NWO grant for a tissue-generating patch to close diaphragmatic defects

21 August 2019

Willeke Daamen and Toin van Kuppevelt, theme Reconstructive and regenerative medicine, were recently awarded a 690 k€ grant by NWO, domain Applied & Engineering Sciences, for the development of advanced patches for closure of diaphragmatic defects in children with congenital diaphragmatic hernia.

read more